AKT and ERK1/2 signaling in intrahepatic cholangiocarcinoma

doi:10.3748/wjg.v13.i48.6470

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 48

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3534)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

309

HTML

2987

Figures (1-5)

238

Sum=3534

Dec 28, 2007 (publication date) through Nov 6, 2024

Times Cited of This Article

Times Cited (43)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Dec 28, 2007; 13(48): 6470-6477
Published online Dec 28, 2007. doi: 10.3748/wjg.v13.i48.6470

Full Size Figure Download Figure

Figure 4 Kaplan-Meier survival plot for disease specific overall survival in the complete series of 59 intrahepatic cholangiocarcinoma in relation to pAKT immunostaining intensity. Log-rank test: P = 0.618.

Citation: Schmitz K, Lang H, Wohlschlaeger J, Sotiropoulos G, Reis H, Schmid K, Baba H. AKT and ERK1/2 signaling in intrahepatic cholangiocarcinoma. World J Gastroenterol 2007; 13(48): 6470-6477
URL: https://www.wjgnet.com/1007-9327/full/v13/i48/6470.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i48.6470